Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
14 May, 2026, 06.53 AM IST
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
08 May, 2026, 11.56 AM IST
Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
01 May, 2026, 02.53 PM IST
Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
29 Apr, 2026, 10.01 PM IST
Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
24 Apr, 2026, 09.41 AM IST
Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
14 Apr, 2026, 08.08 PM IST
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
07 Apr, 2026, 08.58 PM IST
Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
04 Jun, 2021, 08.54 AM IST
Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19The company has received permission for restricted emergency use of its monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 ...
01 Jun, 2021, 06.15 PM IST
Eli Lilly and Co to supply 650,000 more doses of COVID-19 drug to U.S. governmentThe new purchase is part of a U.S. government deal to secure nearly 1 million doses of Lilly's bamlanivimab, a treatment similar to Regener...
03 Dec, 2020, 08.18 AM IST
US allows emergency use of first COVID-19 antibody drugThe Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data showi...
10 Nov, 2020, 08.53 AM IST
2nd study testing a COVID-19 antibody drug has a setbackTests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is...
30 Oct, 2020, 10.53 PM IST
Eli Lilly antibody drug fails in a COVID-19 study; others go onIndependent monitors had paused enrolment in the study two weeks ago because of a possible safety issue. But on Monday, the National Instit...
27 Oct, 2020, 08.30 AM IST
Three local cos working on antibody drugs for CovidBharat Serums, Intas Pharma and Biological E along with ICMR are working on antibody therapies for Covid-19 in India.
13 Oct, 2020, 11.59 PM IST
Next best thing to vaccine: Companies testing antibody drugs to treat, prevent Covid-19Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by trickin...
12 Aug, 2020, 08.11 PM IST
Covid-19: A cure still elusive, but science may find a wayIndia continues to see new cases and is one of the few countries to witness a rise after substantially relaxing lockdown restrictions. Scie...
13 Jun, 2020, 07.24 AM IST